Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 2
1995 2
1996 3
1997 2
1998 3
1999 4
2000 6
2001 4
2002 2
2003 7
2004 8
2005 10
2006 17
2007 20
2008 15
2009 17
2010 21
2011 23
2012 21
2013 13
2014 9
2015 6
2016 8
2017 5
2018 4
2019 5
2020 3
2021 4
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19331218

220 results

Results by year

Filters applied: . Clear all
Page 1
Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
Jones A, O'Brien M, Sommer H, Nowara E, Welt A, Pienkowski T, Rolski J, Pham ML, Perraud K, Trillet-Lenoir V. Jones A, et al. Cancer Chemother Pharmacol. 2010 Mar;65(4):755-63. doi: 10.1007/s00280-009-1081-y. Epub 2009 Aug 9. Cancer Chemother Pharmacol. 2010. PMID: 19669644 Clinical Trial.
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials.
Strada MR, Palumbo R, Bernardo A, Riccardi A, Teragni C, Poggi G, Frascaroli M, Amatu A, Montagna B, Sottotetti F, Tagliaferri B, Bernardo G. Strada MR, et al. Clin Breast Cancer. 2012 Feb;12(1):30-9. doi: 10.1016/j.clbc.2011.11.001. Epub 2011 Dec 6. Clin Breast Cancer. 2012. PMID: 22154360 Clinical Trial.
A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines.
Campone M, Dobrovolskaya N, Tjulandin S, Chen SC, Fourie S, Mefti F, Konstantinova M, Lefresne F, Meheust N, Jassem J. Campone M, et al. Breast J. 2013 May-Jun;19(3):240-9. doi: 10.1111/tbj.12098. Epub 2013 Mar 26. Breast J. 2013. PMID: 23528159 Clinical Trial.
220 results